Back

Selection of pacemaker therapy and outcomes in unexplained syncope

17 March 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster session 2 - Syncope and Bradycardia Clinical EHRA Premium Access EHRA 2019

About the speaker

Photo
Associate Professor Viktor Hamrefors

Lund University, Malmo (Sweden)

15 More presentations in this session

Presentation thumbnail
The predictive value of a multivariate model of autonomic and baroreflex function applied to patients with reflex syncope
Professor S. Laranjo (Lisbon, PT)
Abstract
Presentation thumbnail
POTS serum activates G-protein coupled receptors responsible for cardiovascular homeostasis and pain control
Professor A. Fedorowski (Stockholm, SE)
Abstract Slides
Presentation thumbnail
Cardiovascular neurohormones impact time to onset of vasovagal syncope induced by head-up tilt
Doctor P. Torabi (Vaxjo, SE)
Abstract Slides
Presentation thumbnail
Diagnosing the undiagnosed patient with syncope: Diagnostic yield, accuracy and safety of a tertiary syncope unit
Mr J. de Jong (Amsterdam, NL)
Abstract
Presentation thumbnail
Performance of a new implantable cardiac monitor pause detection algorithm in the presence of low-amplitude R-waves
Doctor J. Toquero Ramos (Majadahonda, ES)
Abstract

Access the full session

Session thumbnail
Poster session 2 - Syncope and Bradycardia

The Event

Event poster

EHRA 2019

17 March - 19 March 2019
You may be interested in
thumbnail
Congress Presentation
How to manage patients with bradycardic phenotype: pace or ablate or...?
thumbnail
Congress Presentation
Young patient with syncopes and seizures: Antiepileptic drugs, pacemaker or cardioneuroablation?
thumbnail
Congress Session
A practical update on diagnosis and treatment of vasovagal syncope

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources